“allergy” Archives

in
Entry Author Date Location
Advisory Body Backs Aimmune Peanut Allergy Drug, Next Up: the FDA 09/13/19 San Francisco
FDA Doesn’t Shell Peanut Allergy Drug Pre-Hearing, Aimmune Shares Climb 09/11/19 San Francisco
DBV Rejoins Peanut Allergy Treatment Race, But Aimmune Takes the Lead 02/13/19 National
Bio Roundup: Big Approvals, ICER Influence, Drug-Price Pushback & More 08/17/18 National
Bio Roundup: Meldonium Slip, Kratom Crackdown, Zinc Fingers & More 02/23/18 National
CertaDose, Preparing to Sell First Product, Adds $5M and J&J Grant 01/04/18 Texas
RA Capital Seeds Peanut Allergy Prevention Startup With $1.7M 06/01/16 Boston
Foresite Capital Keeps Late-Stage Healthcare Focus With $450M Third Fund 07/29/15 San Francisco
Aimmune May Seek Up To $115M in IPO for Allergy Therapy Drug 07/07/15 San Francisco
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase 06/30/15 Boston
La Jolla Institute Extends 25-Year Partnership with Japanese Pharma 07/31/13 San Diego
Thermo Fisher Picks Up One Lambda for Nearly $1B 07/16/12 Boston
Rigel Pockets $130M in Financing, Seeks To Pick up Pfizer’s Ball and Run With it 05/26/11 San Francisco
Report: AstraZeneca to Lay Off 135 in MA 05/19/11 Boston
FDA Approves Sunovion Schizophrenia Drug 10/29/10 Boston
Page 1 of 1